Replies to post #5253 on AVEO Pharmaceuticals, Inc. (AVEO)

[Biotech Pharmer]

The facts are the facts.
https://www.ascopost.com/issues/january-25-2020/tivo-3-third-or-fourth-line-tivozanib-vs-sorafenib-in-metastatic-renal-cell-carcinoma/

[Gungadin1]

Wheres that hugh dumping.